Technology, Healthcare, Real Estate Nov 02, 2021 05:19 PM (GMT+8) · EqualOcean
Cailian news agency, Nov. 2 - Zhende medical announced that due to personal capital needs, Shen Zhendong and Xu Dasheng, the company's directors and deputy general managers, plan to reduce the company's shares by means of centralized competitive trading on the Shanghai Stock Exchange, with a total of no more than 297000 shares, that is, no more than 25% of the total personal holdings, accounting for no more than 0.13% of the company's total share capital. The reduction period shall be within 6 months after 15 trading days from the date of announcement of the reduction plan (November 24, 2021 to May 23, 2022). In case of window period and other circumstances that may not be reduced as specified in relevant laws, regulations and normative documents, the reduction shall not be made.